“Innovative Greeks” is a newly established initiative, a network launched the Hellenic Federation of Enterprises (SEB) and Endeavor Greece, a non-profit organisation that supports high-impact entrepreneurs in emerging markets to fuel economic growth. The aim of the network is to bring together Greek entrepreneurs, investors, managers and researchers across the globe with fast growing Greek startups. Through this open community of knowledge Greek startups will have the opportunity to cooperate with leading companies, exchange know-how, explore new markets and grow.
The two groups, SEV and Endeavor, joined forces to create a community of innovative Greeks that will benefit Greece’s economic prospects, create growth and jobs, and increase the resilience of the Greek economy. The initiative has already gained the support of the American-Hellenic Chamber of Commerce, the Hellenic Initiative, the Hellenic Innovation Network, the ARGO – Brussels Hellenic Network, Greektech, the Con
Record exports for Greece in first 5 months of 2021
sofokleous10.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sofokleous10.gr Daily Mail and Mail on Sunday newspapers.
PM Mitsotakis: Greece is ready for a new leap in development
greekcitytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from greekcitytimes.com Daily Mail and Mail on Sunday newspapers.
Ευρωκίνηση 5/9/2021
ATHENS Businessman Thanassis Lavidas, a majority stockholder of Greek pharmaceuticals Lavipharm, died Saturday aged 73.
He assumed the helm of the family company in 1976, and served as member of the Hellenic Federation of Enterprises (SEV) board for 12 years.
Lavidas also chaired the Greece-US Business Council, and had been recognized by France as a Chevalier of the Legion of Honor in 2011 for promoting dialogue between nations and for the collaboration across the Mediterranean basin countries, especially between Greece and France.
He was also member of Boston-based biotechnology ARIAD s board, which trades on Nasdaq in New York.
Lavidas had Bachelor and Master s degrees in chemistry from Ludwig Maximillian University of Munich, an MBA from Paris-based Institut Supérieur du Marketing et du Management, and a PhD in pharmaceutical chemistry from the University of Athens.